Review

Emerging Treatments for Psoriasis: What Do Interleukin-17 Antagonists Promise?
  • Burhan Engin
  • Muazzez Çiğdem Oba
  • Zekayi Kutlubay
  • Server Serdaroğlu
J Turk Acad Dermatol 2018; 12: 0-0 DOI: 10.6003/jtad.18123r2

Case Report

Two Patients with Psoriasis and Hepatitis B Treated with Secukinumab During COVID-19 Pandemic
  • Melis Gönülal
  • Didem Didar Balcı
J Turk Acad Dermatol 2021; 15: 27-29 DOI: 10.4274/jtad.galenos.2020.46855
Secukinumab-induced Behçet’s Disease in a Patient with Ankylosing Spondylitis Successfully Treated with Certolizumab: A Case Report
  • Yusuf Karabulut
J Turk Acad Dermatol 2022; 16: 50-52 DOI: 10.4274/jtad.galenos.2021.76376
Secukinumab - A New Ray of Hope for the Management of Refractory Hidradenitis Suppurativa
  • Devansi Sarawgi
  • Gobinda Chatterjee
  • Olympia Rudra
  • Pramit Nandy
  • Aniruddha Mandal
J Turk Acad Dermatol 2022; 16: 111-113 DOI: 10.4274/jtad.galenos.2021.91300

About Journal

Forms

Useful Links